APA (7th ed.) Citation

Fiebiger, W. C. C., Scheithauer, W., Traub, T., Kurtaran, A., Gedlicka, C., Kornek, G. V., . . . Raderer, M. (2002). Absence of Therapeutic Efficacy of the Somatostatin Analogue Lanreotide in Advanced Primary Hepatic Cholangiocellular Cancer and Adenocarcinoma of the Gallbladder Despite In Vivo SomatostatinReceptor Expression. Scandinavian Journal of Gastroenterology, 37(2), 222. https://doi.org/10.1080/003655202753416911

Chicago Style (17th ed.) Citation

Fiebiger, W. C. C., W. Scheithauer, T. Traub, A. Kurtaran, C. Gedlicka, G. V. Kornek, I. Virgolini, and M. Raderer. "Absence of Therapeutic Efficacy of the Somatostatin Analogue Lanreotide in Advanced Primary Hepatic Cholangiocellular Cancer and Adenocarcinoma of the Gallbladder Despite In Vivo SomatostatinReceptor Expression." Scandinavian Journal of Gastroenterology 37, no. 2 (2002): 222. https://doi.org/10.1080/003655202753416911.

MLA (9th ed.) Citation

Fiebiger, W. C. C., et al. "Absence of Therapeutic Efficacy of the Somatostatin Analogue Lanreotide in Advanced Primary Hepatic Cholangiocellular Cancer and Adenocarcinoma of the Gallbladder Despite In Vivo SomatostatinReceptor Expression." Scandinavian Journal of Gastroenterology, vol. 37, no. 2, 2002, p. 222, https://doi.org/10.1080/003655202753416911.